BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31936664)

  • 1. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    Yeo C; Han DS; Lee HJ; Lee EO
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.
    Yeo C; Lee HJ; Lee EO
    Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells.
    Han DS; Lee HJ; Lee EO
    Sci Rep; 2022 Nov; 12(1):20125. PubMed ID: 36418859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells.
    Han DS; Lee EO
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.
    Xiao T; Zhong W; Zhao J; Qian B; Liu H; Chen S; Qiao K; Lei Y; Zong S; Wang H; Liang Y; Zhang H; Meng J; Zhou H; Sun T; Liu Y; Yang C
    Cell Death Dis; 2018 Sep; 9(9):906. PubMed ID: 30185783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
    Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
    Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
    De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
    J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTDH in macrophages promotes the vasculogenic mimicry via VEGFA-165/Flt-1 signaling pathway in head and neck squamous cell carcinoma.
    Liu X; Lv Z; Zhou S; Kan S; Liu X; Jing P; Xu W
    Int Immunopharmacol; 2021 Jul; 96():107776. PubMed ID: 34162144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
    Fan X; Huang J; Hu B; Zhou J; Chen L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
    Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
    Tang FY; Nguyen N; Meydani M
    Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
    Han H; Du L; Cao Z; Zhang B; Zhou Q
    Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
    Li Y; Sun B; Zhao X; Zhang D; Wang X; Zhu D; Yang Z; Qiu Z; Ban X
    Exp Mol Pathol; 2015 Apr; 98(2):136-44. PubMed ID: 25661888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
    Hess AR; Seftor EA; Gruman LM; Kinch MS; Seftor RE; Hendrix MJ
    Cancer Biol Ther; 2006 Feb; 5(2):228-33. PubMed ID: 16481735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
    Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
    J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.